跳至主要内容
临床试验/NCT04544150
NCT04544150已完成不适用

Gastrointestinal Manifestations in COVID-19: Symptoms and Signs and Its Impact on the Outcome

Assiut University1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
220
试验地点
1
主要终点
frequency of GIT symptoms among patients with COVID-19 infection

研究概览

简要总结

many patients with confirmed infection with COVID-19 suffer from different symptoms and signs of gastrointestinal symptoms

详细描述

many patients with COVID1-9 infection experienced many intestinal symptoms mainly abdominal pain, vomiting, and diarrhea. This study aimed to assess the frequency of GIT manifestations among patients with COVID-19 and its impact on the outcome

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • all patients with COVID19

排除标准

  • patient refusal to participate in the study

结局指标

主要结局

frequency of GIT symptoms among patients with COVID-19 infection

时间窗: Baseline

any GIT symptoms in such patients were recorded

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohammed Abu Elfatth

Al-rahji University Hospital, Faculty of Medicine, Assiut, Egypt

Assiut University

研究点 (1)

Loading locations...

相似试验

Gastrointestinal Manifestations Among Patients With... | 临床试验